Spectrum of opportunistic fungal lung co-infections in COVID-19: What the radiologist needs to know

Fungal lung co-infections associated with COVID-19 may occur in severely ill patients or those with underlying co-morbidities, and immunosuppression. The most common invasive fungal infections are caused by aspergillosis, mucormycosis, pneumocystis, cryptococcus, and candida. Radiologists integrate...

Full description

Saved in:
Bibliographic Details
Published in:Radiología (English ed.) 2022-11, Vol.64 (6), p.533-541
Main Authors: Nair, A.V., Ramanathan, S., Sanghavi, P., Manchikanti, V., Satheesh, S., Al-Heidous, M., Jajodia, A., Macdonald, D. Blair
Format: Article
Language:English
Subjects:
Aspergillosis
Aspergilosis
Candida
COVID-19
Criptococo
Cryptococcus
Cándida
Mucormicosis
Mucormycosis
Pneumocystis
SARS-CoV-2
Update in Radiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Fungal lung co-infections associated with COVID-19 may occur in severely ill patients or those with underlying co-morbidities, and immunosuppression. The most common invasive fungal infections are caused by aspergillosis, mucormycosis, pneumocystis, cryptococcus, and candida. Radiologists integrate the clinical disease features with the CT pattern-based approach and play a crucial role in identifying these co-infections in COVID-19 to assist clinicians to make a confident diagnosis, initiate treatment and prevent complications. Las coinfecciones pulmonares fúngicas asociadas a la COVID-19 pueden ocurrir en pacientes gravemente enfermos o con comorbilidades subyacentes e inmunosupresión. Las infecciones fúngicas invasivas más comunes son causadas por aspergilosis, mucormicosis, y las debidas a Pneumocystis, criptococo y cándida. Los radiólogos integran las características clínicas de la enfermedad con el enfoque basado en patrones de TAC y desempeñan un papel crucial en la identificación de estas coinfecciones en la COVID-19 para ayudar a los médicos a realizar un diagnóstico seguro, iniciar el tratamiento y prevenir complicaciones.
ISSN:2173-5107
2173-5107
DOI:10.1016/j.rxeng.2022.06.004